Medical Device News Magazine

Airnov Healthcare Packaging Celebrates 5 Years of Manufacturing in India

Cuddalore facility continues to serve a growing demand in the Indian market and represents an important hub for future regional growth. The company will exhibit a broad range of healthcare packaging solutions, including HAT-B®, EQius®, laser marked canisters and DRICARD™ at CPHI India 2022.

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, has surpassed five years of manufacturing at its production facility in India.

The plant, located in Cuddalore which sits south of Chennai in the Indian state of Tamil Nadu, is operated by a workforce of around 40 dedicated employees and is ISO 9001 and ISO 15378.

Beginning production in 2017, the Indian site is an important local hub for Airnov serving what is a growing national and regional market. It will also prove critical in meeting future growth in demand for Airnov’s healthcare packaging solutions.

Shrikar Trikannad, Head of sales India at Airnov, commented: “We continue to see great promise in the Indian market, which is proving very receptive to the pioneering products that we are able to bring to customers.”

“As we look ahead to the next five years, India will continue to play a key role in our business planning.”

The milestone arrives as Airnov exhibits at CPHI 2022 in India, a leading tradeshow connecting stakeholders in the pharmaceutical sector.

In particular, guests are invited to discover a range of products. These include:

  • HAT®-B: Airnov’s latest innovative vial, is designed to limit carbon footprints with an optimized amount of plastic. They contain an adjustable desiccant quantity and incorporate versatile sorbent materials to fit stability requirements. The vial, suitable for the pharmaceutical, diagnostic and nutraceutical markets, is available in two sizes and is compatible with existing filling lines.
  • EQius®: Airnov’s equilibrium relative humidity stabilizers are sorbent products that can maintain a specific required humidity level in pharmaceuticals. They are particularly designed to protect dry powder inhalers, gelatine capsules, and gummies. The development of Airnov’s EQius portfolio will help customers’ control relative humidity from 10% to 95%, and meet specific needs for the pharmaceutical and nutraceutical markets.
  • Laser marked canisters: These canisters use laser technology to create visible marks on the canister body without inks, varnishes, adhesives, and other extraneous materials for a more sustainable product with less risk of contamination. The portfolio will be complete this year with the release of 2g and 3g.
  • DRICARD: The new line of blue Dricard boasts double thickness, which allows for twice the moisture adsorption capacity across the same sized product. It also enables 80% less ink to be used, providing an important sustainability benefit.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”